Status of Converted Series B Preferred Stock. If any shares of Series B Preferred Stock shall be converted or reacquired by the Corporation, such shares shall resume the status of authorized but unissued shares of preferred stock and shall no longer be designated as Series B Preferred Stock.
Appears in 2 contracts
Samples: Securities Exchange Agreement (Oncothyreon Inc.), Underwriting Agreement (Oncothyreon Inc.)
Status of Converted Series B Preferred Stock. If any shares of Series B Preferred Stock shall be converted or reacquired by the Corporation, such shares shall shall, without need for any action by the Board of Directors or otherwise, resume the status of authorized but unissued shares of preferred stock and shall no longer be designated as Series B Preferred Stock.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Leap Therapeutics, Inc.), 3(a)(9) Exchange Agreement (Pieris Pharmaceuticals, Inc.)
Status of Converted Series B Preferred Stock. If any shares of Series B Preferred Stock shall be converted or reacquired by the Corporation, such shares shall shall, without need for any action by the Board of Directors or otherwise, resume the status of authorized but unissued shares of preferred stock Preferred Stock and shall no longer be designated as Series B Preferred Stock.
Appears in 1 contract
Status of Converted Series B Preferred Stock. If any shares of Series B Preferred Stock shall be converted or reacquired redeemed by the Corporation, such shares shall resume the status of authorized but unissued shares of preferred stock and shall no longer be designated as Series B Preferred Stock.
Appears in 1 contract
Samples: Securities Purchase and Exchange Agreement (Interpace Biosciences, Inc.)
Status of Converted Series B Preferred Stock. If any shares of Series B Preferred Stock shall be converted or reacquired by the Corporation, such shares shall resume the status of authorized but unissued shares of preferred stock and shall no longer be designated as Series B Preferred Stock. [ ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Appears in 1 contract
